The Brazilian Health Ministry does not rule out the possibility that Russia’s Sputnik V COVID-19 vaccine can still be used as part of the national immunization plan (PNI) in 2022 despite the restrictions currently placed on its use by Anvisa, national healthcare regulator, Health Minister Marcelo Queiroga said, Trend reports with reference to TASS.
"Considering the number of doses which we plan to get by the end of the year and the import conditions set by Anvisa, we can do without is (Sputnik V). At the same time, it can be still considered for the PNI goals in Brazil in the future if the vaccine obtains an emergency use authorization or a permanent registration," the minister explained.